FIELD: medicine.
SUBSTANCE: invention relates to biology and medicine and concerns a novel polypeptide composition representing a fraction of polypeptides recovered from bovine cerebral cortex. Disclosed also is a pharmaceutical composition comprising said composition of polypeptides, and use for normalizing cerebral function, for example, stroke, cerebral effusions, arresting convulsive syndrome, recovering disturbed cerebral reflex activity, memory, coordination of movements by introduction, as well as neuroprotector.
EFFECT: disclosed is a composition of polypeptides having the property of normalizing cerebral functions.
11 cl, 6 dwg, 9 ex
Title | Year | Author | Number |
---|---|---|---|
POLYPEPTIDE COMPOSITION HAVING PROPERTY OF NORMALIZING CEREBRAL FUNCTIONS | 2019 |
|
RU2727154C1 |
POLYPEPTIDE COMPOSITION HAVING PROPERTY OF NORMALIZING CEREBRAL FUNCTIONS | 2019 |
|
RU2726854C1 |
POLYPEPTIDE COMPOSITION HAVING PROPERTY OF NORMALIZING CEREBRAL FUNCTIONS | 2019 |
|
RU2727162C1 |
POLYPEPTIDE COMPOSITION HAVING PROPERTY OF NORMALIZING CEREBRAL FUNCTIONS | 2019 |
|
RU2727167C1 |
POLYPEPTIDE COMPOSITION HAVING PROPERTY OF NORMALIZING CEREBRAL FUNCTIONS | 2019 |
|
RU2727586C1 |
PROTEIN-POLYPEPTIDE COMPLEX POSSESSING ANTIHYPOXIC, TISSUE-SPECIFIC REPARATIVE ACTION ON CENTRAL AND PERIPHERAL NERVOUS SYSTEMS, METHOD FOR PREPARING IT, AND PHARMACEUTICAL COMPOSITION THEREOF | 2011 |
|
RU2485132C2 |
METHOD FOR PREPARING BIOLOGICALLY ACTIVE COMPLEX AND BIOLOGICALLY ACTIVE PROTEIN-POLYPEPTIDE COMPLEX | 2010 |
|
RU2428196C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING CENTRAL AND PERIPHERAL NERVOUS SYSTEM DISORDERS OF CARDIOVASCULAR, TRAUMATIC, TOXIC, HYPOXIC AND AUTOIMMUNE GENESIS | 2010 |
|
RU2445106C1 |
PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF NEUROLOGIC DISEASES | 2007 |
|
RU2335296C1 |
METHOD OF TREATING ACUTE ISCHEMIC AND HEMORRHAGIC CEREBROVASCULAR DISEASE | 2010 |
|
RU2477637C2 |
Authors
Dates
2020-07-21—Published
2019-09-17—Filed